Search PubMed⌕ Search

Biomedical subjects

S B Vik

Publications and source records attributed to S B Vik.

25 records · Page 2Linked to original sources
PubMed1984

Inhibition of mitochondrial NADH:ubiquinone oxidoreductase by ethoxyformic anhydride.

The NADH:ubiquinone, but not the NADH:ferricyanide, reductase activity of mitochondrial complex I (NADH:ubiquinone oxidoreductase) is inhibited by incubation of the enzyme at pH 6.0 and 0 degree C with ethoxyformic anhydride (EFA), and the inhibition is partially reversed by subsequent incubation of EFA-treated complex I with hydroxylamine. These results and spectral changes of EFA-treated complex I in the u.v. region are consistent with modification of essential histidyl or tyrosyl residues between the primary NADH dehydrogenase and the site of ubiquinone reduction. Treatment of complex I with EFA in the presence of high concentrations of Seconal or Demerol did not protect against EFA inactivation, suggesting that the site of EFA modification may not be the same as the inhibiton sites of Seconal and Demerol. However, the presence of NADH during incubation of complex I with EFA greatly enhanced the inhibition rate, indicating that the reduced conformation of complex I is more susceptible to attack by EFA.

Animals↗
PubMed1982

Reversible inhibition of the mitochondrial ubiquinol-cytochrome c oxidoreductase complex (complex III) by ethoxyformic anhydride.

The mitochondrial ubiquinol-cytochrome c oxidoreductase (complex III) is inhibited by ethoxyformic anhydride (EFA). The inhibition is readily reversed by hydroxylamine, suggesting the involvement of essential histidyl or possibly tyrosyl residues. The spectrum of ethoxyformylated complex III in the UV region showed a peak at 238 nm, indicative of N-(ethoxyformyl)histidine. Addition of hydroxylamine caused a large decrease of the 238-nm peak, which amounted to 16 mol of (ethoxyformyl)histidine/mol of cytochrome c1. Hydroxylamine addition to ethoxyformylated complex III also caused a small change at about 280 nm, which could be due to reversal of 1.6 O-ethoxyformylated tyrosyl residues/mol of cytochrome c1. Among many inhibitors of the cytochrome bc1 region of the respiratory chain, EFA is the only reagent known to cause reversible inhibition by covalent modification of amino acid residues. The inhibition site of EFA was determined to be between cytochromes b-562 and c1. However, unlike antimycin, which also inhibits in the same region, EFA did not promote the reduction of cytochrome b-566 in particles treated with substrates. In addition, it was found that EFA inhibits proton translocation in the cytochrome bc1 region and is a more effective electron transport inhibitor when added to reduced particles as compared to oxidized particles. These results together with the strong possibility that the EFA target is a histidyl or possibly a tyrosyl residue have been discussed in relation to the mechanism of proton translocation by complex III.

Anaerobiosis↗
PubMed1982

Substrate binding affinity changes in mitochondrial energy-linked reactions.

The effects of uncouplers and valinomycin plus nigericin (in the presence of K+) were studied on the apparent Km for substrates and apparent Vmax of the following energy-linked reactions catalyzed by submitochondrial particles: oxidative phosphorylation, NTP-33Pi exchange, ATP-driven electron transfer from succinate to NAD, and respiration-driven transhydrogenation from NADH to 3-acetylpyridine adenine dinucleotide phosphate. In all cases, partially uncoupling (up to 90%) concentrations of uncouplers of valinomycin plus nigericin were found to decrease apparent Vmax and to increase apparent Km. Results plotted as ln (Vmax/Km) versus the concentration of uncouplers or ionophores showed a linear decrease of the former as a function of increasing perturbant concentration (i.e., decreasing free energy). Because Vmax/Km may be considered as a measure of the apparent first-order rate constant for enzyme-substrate interaction and reflects the affinity between enzyme and substrate to form a complex, the results are consistent with the interpretation that membrane energization leads to a change in enzyme conformation with the resultant increase in enzyme-substrate affinity and facilitation of the reaction rate under consideration. The significance of these findings with respect to the mechanism of action of the energy-transducing systems studied is discussed.

Adenosine Triphosphate↗
PubMed1981

Possible occurrence and role of an essential histidyl residue in succinate dehydrogenase.

Diethylpyrocarbonate (Et2PC) inhibits the succinate dehydrogenase [succinate:(acceptor) oxidoreductase, EC 1.3.99.1] activity of submitochondrial particles, Complex II (succinate:ubiquinone oxidoreductase), and the soluble, pure succinate dehydrogenase. The reaction order with respect to Et2PC concentration is close to unity, suggesting modification of one essential residue per active unit of the enzyme. The pH profile of Et2PC inhibition, the partial reversal of inhibition by hydroxylamine, and the spectral change of the Et2PC-treated enzyme in the UV region suggest modification of a histidyl residue. Succinate dehydrogenase activity can be protected against Et2PC inhibition by succinate, fumarate, malonate, or oxaloacetate (also by activating anions such as ClO4(-) and Br-), suggesting that the Et2PC-modified essential residue might be at the active site. In both submitochondrial particles and the purified enzyme, succinate dehydrogenase activity is highest and relatively constant at pH greater than or equal to 7.0 and diminishes precipitously at pH less than 7.0. By contrast, fumarate reductase activity is highest at pH less than or equal to 7.0 and diminishes at pH greater than 7.0. These results are consistent with the possible participation of the unprotonated and protonated forms of the imidazole moiety of the putative histidyl residue, respectively, in succinate oxidation and fumarate reduction.

Animals↗
PubMed1981

Diphosphatidylglycerol is required for optimal activity of beef heart cytochrome c oxidase.

Isolated beef heart cytochrome c oxidase (ferrocytochrome c:oxygen oxidoreductase, EC 1.9.3.1) contains four or five molecules of tightly bound diphosphatidylglycerol per monomer (2-heme complex). This lipid could be removed in part, or wholly, by mixing the enzyme with high concentrations of Triton X-100 and then centrifuging the mixture through a glycerol gradient equilibrated in the same detergent. Cytochrome c oxidase retaining three or more diphosphatidylglycerol molecules per monomer was fully active when assayed in 1-oleoyl lysophosphatidylcholine. Upon removal of one or more of these diphosphatidylglycerols, enzymic activity was lost. Full activation could be obtained by adding diphosphatidylglycerol to the assay mixture along with lysophosphatidylcholine but not by adding phosphatidylcholine or phosphatidylethanolamine. Direct binding experiments, kinetic studies, and previous work using arylazidocytochrome c derivatives [Bisson, R., Jacobs, B. & Capaldi, R. A. (1980) Biochemistry 10, 4173-4178], indicate that diphosphatidylglycerol is involved in binding of substrate cytochrome c to cytochrome c oxidase.

Animals↗
PubMed1977

Lipid requirements for cytochrome c oxidase activity.

Cytochrome c oxidase depleted of endogenous lipid by detergent exchange has been reconstituted into vesicles with synthetic lipids of known head group and fatty acid composition and enzymic activities have been measured. No evidence for head group specificity was found. However, the enzyme does require the fluid environment provided by unsaturated fatty acids. The state of dispersion of the enzyme was found to affect the activities regenerated in reconstitution studies. The highest activities were obtained using lysolecithin containing an oleoyl fatty acid as the lipid component.

Animals↗